Brian Brady Adds 4,032 Shares to 453,020 IZEA Holdings After Q3 Fee Award

Rhea-AI Filing Summary

Brian W. Brady, a director of IZEA Worldwide, Inc. (IZEA), received 4,032 restricted shares on 09/30/2025 as compensation for Q3 2025 director fees. The award was valued at $15,000 based on the closing price of $3.7200 on the grant date and vested at grant, giving him immediate ownership. After the transaction Brady beneficially owned 453,020 shares. The Form 4 filing was executed by an attorney-in-fact and signed on 10/01/2025.

Positive

• Director compensation paid in equity: 4,032 restricted shares awarded for Q3 2025 director fees.
• Award vested at grant: The shares vested on the grant date, giving immediate ownership.
• Clear valuation disclosed: Award valued at $15,000 based on $3.7200 closing price on 09/30/2025.
• Beneficial ownership updated: Reporting person beneficially owns 453,020 shares after the transaction.

Negative

• None.

Insights

Financial Analyst

TL;DR: Director received immediaterestricted stock worth $15,000, increasing reported beneficial ownership to 453,020 shares.

The filing documents a routine director compensation payment in equity rather than cash. The award consisted of 4,032 restricted shares valued at $3.72 each and vested at grant, so the director obtained full ownership immediately. This raises reported beneficial ownership and demonstrates use of equity-based director compensation. There are no derivative transactions reported and no other material changes disclosed.

Corporate Governance Expert

TL;DR: Governance action is standard: equity granted for director fees and vested on grant, disclosed via Form 4.

The Form 4 shows transparent reporting of a director fee settlement in restricted stock, explicitly stating vesting at grant and the valuation method tied to the closing market price. The signature by an attorney-in-fact complies with execution formalities. The disclosure is concise and limited to this single, non-derivative equity grant.

Insider Trade Summary

Net Buyer: 4,032 shares

Net Buy 1 txn

Insider Brady Brian W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,032	$0.00	$0.00

Holdings After Transaction: Common Stock — 453,020 shares (Direct)

Footnotes (1)

1. F1. Restricted Stock received for Q3 2025 director fees valued at $15,000 based on the closing market price of $3.7200 on the grant date of September 30, 2025. Award vests at the grant date.

FAQ

What transaction did Brian W. Brady report on the IZEA Form 4?

He received 4,032 restricted shares as payment for Q3 2025 director fees, reported on 09/30/2025.

How was the 4,032-share award valued on the Form 4?

Valued at $15,000 based on the closing market price of $3.7200 on the grant date of 09/30/2025.

Did the restricted shares vest immediately?

Yes. The award vested at the grant date, giving immediate ownership.

How many IZEA shares does Brian Brady beneficially own after this transaction?

453,020 shares following the reported transaction.

Who signed the Form 4 filing for Brian W. Brady?

Peter J. Biere signed as attorney-in-fact on 10/01/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/01/2025 - 04:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Brady Brian W

(Last) (First) (Middle)

1317 EDGEWATER DR #1880

(Street)

ORLANDO FL 32804

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IZEA Worldwide, Inc. [ IZEA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		A		4,032(1)	A	(1)	453,020	D(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock received for Q3 2025 director fees valued at $15,000 based on the closing market price of $3.7200 on the grant date of September 30, 2025. Award vests at the grant date.

Remarks:

	By: /s/ Peter J. Biere as attorney-in-fact for Brian Brady	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.